What we heard from CCOs (VIDEO)
This excerpt from our Pharmaceutical Executive presentation on launching in the rare disease market offers insights from CCOs and executives. A key concern is managing cash flow and resources, including hiring strategies and choosing between commercial light or heavy models. Executives often delay decisions to optimize launch conditions, balancing ideal and minimal launches that can expand over time. Data analytics teams emphasize the importance of data access for informed decision-making.
Market access teams emphasize early hiring to engage external stakeholders, particularly payers. A significant challenge is finding individuals who can transition from big pharma to the fast-paced biotech environment, where multitasking is essential.
Watch the full Pharmaceutical Executive presentation:
Other Rare Disease Resources:
Rare Disease Landscape: Parameters for Success (VIDEO)
The video discusses key factors for success in rare disease markets through the five P’s: People, Product, Payers, Promotion, and Placement.
Identify Rare Disease Product Launch Archetypes
Learn how to identify your rare disease product launch archetype to optimize your launch planning.
